BRNS Barinthus Biotherapeutics Corp: Multiplikator Forward P/S

Lambang korporat lan logo Barinthus Biotherapeutics (BRNS)

P/S expectations reflect the current valuation of Barinthus Biotherapeutics (BRNS), where the metric stands at 2.90. The biotech's financial stability is supported by government grants and R&D alliances that reduce costs. Patent protection for viral vectors and strict regulatory requirements create a significant barrier to entry for competitors. Growth potential is tied to the upcoming results of hepatitis B vaccine trials.

Barinthus Biotherapeutics plc - Multiplikator Forward P/S BRNS (periode 21.02.2024 - 10.11.2025)

Rincian analitis perusahaan Barinthus Biotherapeutics

- rega saiki lan proyeksi nilai saham:
Pambiji fundamental perusahaan:Barinthus Biotherapeutics plc (BRNS)
Sampel barang Barinthus Biotherapeutics

The development of the Barinthus Biotherapeutics (BRNS) immunological ecosystem depends directly on R&D results and the influx of partners within clinical trials. The forward P/S valuation reflects the risk of failing to achieve these goals by discounting expected revenue through the cost of capital, where an inflated indicator signals excessive market expectations, while a low one indicates undervaluation or a systemic crisis in the business model.

Perusahaan pesaing

Multiplikator Forward P/S ARGX (argenx.com)|BioNTech Group (BNTX) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|ABIVAX - Multiplikator Forward P/S|ADMA - Multiplikator Forward P/S|Protagonist (PTGX) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan Immunovant Inc|Rasio rega marang prakiraan pendapatan Kiniksa Pharmaceuticals|Grifols Group (GRFS) - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan Adaptive Biotechnologies Corp (ADPT)|Rasio rega marang prakiraan pendapatan CLDX (Celldex Therapeutics)|Rasio rega marang prakiraan pendapatan Aurinia Pharma AUPH|Rega forward marang dodolan BCRX|VERA: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan DNTH (Dianthus Therapeutics)|Pharvaris N.V. (PHVS) - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep AbCellera Biologics (ABCL)|TRML (Tourmaline Bio Inc) - Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan PGEN (Intrexon)|Multiplikator forward rega marang pendapatan PHAR (Pharming)|NKTR (Nektar) - Rega forward marang dodolan|Multiplikator Forward P/S UPB (upstreambio.com)|ZBIO (Zenas Biopharma Inc) - Rega mangsa ngarep marang pendapatan|IMNM - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake Gossamer Bio Inc GOSS|KALV: Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Septerna Pharma|PVLA (Pieris Corp) - Multiplikator Forward P/S|Rasio rega marang prakiraan pendapatan SVRA|Multiplikator Forward P/S RIGL|Multiplikator forward rega marang pendapatan AnaptysBio Corp ANAB|Astria Therapeutics Inc - Multiplikator forward rega marang pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake enGene Holdings Inc. (ENGN)|RAPT Therapeutics Inc. - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Aerovate Therapeutics, Inc.|ACRS (Aclaris Therapeutics) - Multiplikator forward rega marang pendapatan|KYTX: Rasio rega marang pendapatan sing dikarepake|Rasio rega marang prakiraan pendapatan Tiziana Life Sciences|Cabaletta Bio, Inc (CABA) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator forward rega marang pendapatan VTYX (Ventyx Biosciences)|Rasio kapitalisasi marang dodolan sing dikarepake theratech.com|Multiplikator Forward P/S AVTX (Avalo Therapeutics, Inc.)|Multiplikator Forward P/S Eledon Pharmaceuticals Inc. ELDN|AGEN: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan CLYM (Climb Bio, Inc)|ZURA: Multiplikator Forward P/S|aTyr Pharma, Inc. - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Adagene Inc.|IMA: Rega forward marang dodolan|Multiplikator Forward P/S STTK|Multiplikator forward rega marang pendapatan Equillium Bio EQ|Rasio rega marang prakiraan pendapatan Connect Biopharma CNTB|IMUX - Multiplikator forward rega marang pendapatan|ATRA - Rasio rega marang prakiraan pendapatan|InflaRx NV (IFRX) - Multiplikator forward rega marang pendapatan|XFOR (X4 Pharmaceuticals Inc.) - Multiplikator forward rega marang pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Adicet Bio Inc. (ACET)|Rasio rega marang prakiraan pendapatan celularity.com|Multiplikator forward rega marang pendapatan inmunebio.com (INMB)|Multiplikator Forward P/S KZR|Multiplikator Forward P/S SAB Biotherapeutics, Inc (SABS)|Multiplikator Forward P/S AKTX (Akari Therapeutics, Plc)|Multiplikator Forward P/S enlivex.com ENLV|QTTB: Multiplikator forward rega marang pendapatan|GOVX - Multiplikator Forward P/S|Edesa Biotech Inc (EDSA) - Rasio rega marang prakiraan pendapatan|IBIO - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan carismatx.com|XTLB: Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Bolt Biotherapeutics Inc. (BOLT)|HCW Biologics - Kapitalisasi marang prakiraan pendapatan|Rasio rega marang prakiraan pendapatan aptevotherapeutics.com APVO|AIM - Multiplikator forward rega marang pendapatan|Aditxt - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake GRI Bio Corporation GRI|xortx.com (XRTX) - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep reshapelifesciences.com (HIND)|Rasio rega marang prakiraan pendapatan Revelation Bio|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Indaptus Therapeutics, Inc. INDP|Rasio rega marang prakiraan pendapatan BiondVax Pharmaceuticals (SCNI)|Multiplikator forward rega marang pendapatan CalciMedica CALI|Rasio rega marang prakiraan pendapatan Affimed AFMD|ALLK - Multiplikator forward rega marang pendapatan|HOOKIPA Pharma, Inc. - Multiplikator Forward P/S|Rega forward marang dodolan IGMS (igmbio.com)|ITOS (iTeos Therapeutics, Inc.) - Multiplikator forward rega marang pendapatan|Ocean Biomedical Corp (OCEA) - Multiplikator Forward P/S|Rasio rega marang prakiraan pendapatan TC BioPharm (Holdings) PLC|Multiplikator Forward P/S thirdharmonicbio.com